Q
Qing Liu
Researcher at Central South University
Publications - 122
Citations - 1879
Qing Liu is an academic researcher from Central South University. The author has contributed to research in topics: Glioma & Medicine. The author has an hindex of 20, co-authored 95 publications receiving 1299 citations.
Papers
More filters
Journal ArticleDOI
LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
TL;DR: Observations suggest CASC2 up‐regulates PTEN through direct inhibiting miR‐181a and plays an important role in glioma sensitivity to TMZ and may serve as a potential target for cancer diagnosis and treatment.
Journal ArticleDOI
LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway.
TL;DR: It is suggested that XIST can amplify the chemoresistance of glioma cell lines to TMZ through directly targetting miR-29c via SP1 and MGMT and may be a potential therapeutic target forglioma treatment.
Journal ArticleDOI
MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ
Jian Yuan,Gelei Xiao,Gang Peng,Dingyang Liu,Zeyou Wang,Yiwei Liao,Qing Liu,Minghua Wu,Xianrui Yuan +8 more
TL;DR: It is found that miR-125a-5p is an important regulator of TAZ in glioma cells by directly targeting the TAZ 3' UTR and also demonstrated a tumor suppressor role of miGlioblastoma cells.
Journal ArticleDOI
The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
TL;DR: Investigation of the role of H19 in human glioma cell lines and clinical tumor samples indicated that H19 might regulate the tumor growth and metastasis via miR-140 dependent iASPP regulation.
Journal ArticleDOI
Anti-Cancer Effect of Metabotropic Glutamate Receptor 1 Inhibition in Human Glioma U87 Cells: Involvement of PI3K/ Akt/mTOR Pathway
Chi Zhang,Xianrui Yuan,Haoyu Li,Zijin Zhao,Yiwei Liao,Xiangyu Wang,Jun Su,Shu-shan Sang,Qing Liu +8 more
TL;DR: The remarkable efficiency of mGluR1 inhibition to induce cell death in U87 cells may find therapeutic application for the treatment of glioma patients.